DUBLIN--(BUSINESS WIRE)--The "Vernal Keratoconjunctivitis (VKC) Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth ...
Dublin, July 15, 2020 (GLOBE NEWSWIRE) -- The "Vernal Keratoconjunctivitis (VKC) Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an ...
Please provide your email address to receive an email when new articles are posted on . In June 2021, Verkazia was approved for the treatment of vernal keratoconjunctivitis in children and adults. OSN ...
Vernal keratoconjunctivitis (VKC) is a chronic, bilateral, allergic condition primarily affecting children and young adults. It is a seasonal allergic inflammatory disease of the eye with episodes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results